National trends in hydroxyurea and opioid prescribing for sickle cell disease by office‐based physicians in the United States, 1997‐2017-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

National trends in hydroxyurea and opioid prescribing for sickle cell disease by office‐based physicians in the United States, 1997‐2017

Published:2019-07-22 Issue:9 Volume:28 Page:1246-1250
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Su Zhuo Tony¹^ORCID,Segal Jodi Beth¹²,Lanzkron Sophie³,Ogunsile Foluso Joy³

Affiliation:

1. Division of General Internal Medicine, Department of MedicineJohns Hopkins University School of Medicine Baltimore MD USA

2. Center for Health Services and Outcomes ResearchJohns Hopkins Bloomberg School of Public Health Baltimore MD USA

3. Division of Hematology, Department of MedicineJohns Hopkins University School of Medicine Baltimore MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4860

Reference15 articles.

1. Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia

2. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

3. Hydroxyurea use in patients with sickle cell disease in a Medicaid population

4. Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilization

5. National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)—A randomized, placebo‐controlled phase II feasibility/pilot study;American Journal of Hematology;2024-07-02

2. Disease‐modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults;Pediatric Blood & Cancer;2024-04-15

3. Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy;American Journal of Obstetrics and Gynecology;2024-02

4. A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease;Blood Advances;2023-11-29

5. Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators;British Journal of Haematology;2023-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3